Abstract
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Author(s): Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
Issue: Mar/Apr 2016 - Volume 20, Number 2
Page(s): 148-154
Abstract
Closed-system transfer devices enhance the drug handlers’ protection against hazardous drugs exposure by prohibiting the escape of liquid or vapor from the system. PhaSeal (Becton Dickinson), a reference closed-system transfer device, includes a vial protector with an expansion chamber, and an injector with an enclosed needle. VialShield (CareFusion) is another more recent closed-system transfer device including an expansion chamber and a non-return valve, designed to be used in association with Texium (CareFusion), a closed, needlefree male luer with its preassembled syringe. Evaluation of VialShield/Texium was done comparatively to a classic spike device (Spike Swan, Codan) and PhaSeal. Evaluation methods consisted in practical evaluation by pharmacy technicians (evaluation of ease to use by nine operators in practical conditions during a complete week of production), microbiological safety performance (by Media Fill Test), and leakage assessment (fluorescein, titanium tetrachloride smoke, and radioactive tracer). Results showed that 100% of those operators evaluated would be ready to use VialShield/Texium for daily use, whereas only 75% of them would be ready to use PhaSeal. The use of PhaSeal and VialShield/Texium increased the duration of preparations compared to Spike Swan. No microbiological growth was observed with any of the three devices. A leakage of smoke was observed only with Spike Swan. Fluorescein leakage assessment confirmed that PhaSeal is a performing closed system with a dry connection. Spike Swan showed fluorescein leaks. Fluorescein drops were visible on the connection sites of the VialShield/Texium. Nevertheless, no fluorescein was found on compress after connections swapping. Transfer performance, assessed using technetium-99m, was 98.1 ± 1.4%, 97.9 ± 1.1% and 97.0 ± 1.3% and dead volume of the devices, were 1.0 ± 0.8%, 1.7 ± 0.6%, and 3.0 ± 1.1% for Spike Swan, PhaSeal, and VialShield/Texium, respectively. VialShield/Texium appeared as a very interesting device with performances close to PhaSeal (except dry connection), with a higher satisfaction assessment from the operators.
Related Keywords
- cytotoxic drug preparations
- hazardous drug handling
- closed system transfer devices
- environmental contamination
- PhaSeal
- VialShield
- Texium
- ease of use
- microbiological safety performance
- media fill test
- leakage assessment
- transfer performance
- pharmacy technician
- production workflow
Related Categories
- ENVIRONMENTAL
- PARENTERALS
- PEER-REVIEWED
- QUALITY CONTROL
- HAZARDOUS DRUGS
Related Articles from IJPC
Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
---|---|
Mar/Apr 2016
Pg. 148-154
|
|
Sep/Oct 2012
Pg. 431-433
|
|
Jan/Feb 2022
Pg. 72-79
|
|
Nov/Dec 2021
Pg. 515-522
|
|
Sep/Oct 2022
Pg. 358-362
|
Author(s):
Lopez C Vidal, Rios GL Quito
|
Jan/Feb 2020
Pg. 30-36
|
Author(s):
Dillon L R
|
Mar/Apr 2023
Pg. 154-159
|
|
Jul/Aug 2023
Pg. 340-346
|
|
Nov/Dec 2019
Pg. 454-461
|
|
Mar/Apr 2018
Pg. 108-121
|
|
Mar/Apr 2013
Pg. 100-110
|
Author(s):
Macklin Denise, Blackburn Paul L
|
Jul/Aug 2000
Pg. 261-263
|
Author(s):
Lau Kellie
|
Sep/Oct 2017
Pg. 356
|
Author(s):
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 47-56
|
Author(s):
Akers Michael J
|
Mar/Apr 2014
Pg. 94-99
|
Author(s):
Marks Zach
|
Jan/Feb 2007
Pg. 50-51
|
Author(s):
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 446-448
|
Author(s):
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 456-460
|
Author(s):
Lyon Joanna
|
May/Jun 2019
Pg. 182-186
|
Author(s):
Dillon L Rad
|
Jul/Aug 2011
Pg. 308-315
|
Author(s):
Allen Loyd V Jr
|